🧠 Prolactin Came Back High

What this panel can settle, and by what logic

Eight markers that answer the only two questions a raised prolactin poses: is the number real, and has it done anything.

1. LH & FSH with Total Testosterone and Estradiol, Sensitive (LC/MS-MS) decide whether the prolactin matters. A raised prolactin that has suppressed nothing is a different situation from one sitting above suppressed gonadotropins and a low sex hormone. The second is the one with consequences for fertility and for bone, and it is the pattern that drives management in the international consensus Petersenn 2023.
2. TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) catches the cause that is fixed by treating something else. Primary hypothyroidism raises prolactin, and correcting the thyroid corrects it. TSH alone is not enough to make that call, because a TSH result has several documented traps of its own Razvi 2019.
3. IGF-1 (Insulin-like Growth Factor 1) screens for the tumor that secretes two things. Pituitary adenomas co-secreting growth hormone and prolactin exist, and the management is not the same as for a pure prolactinoma Petersenn 2023. IGF-1 is the stable downstream readout that a random growth hormone level cannot give.
4. Comprehensive Metabolic Panel (CMP) carries kidney and liver function, and reduced filtration raises prolactin by reducing its clearance rather than by increasing its production.
5. The testosterone here is measured by mass spectrometry and equilibrium dialysis so that the same panel works at male and female concentrations, which direct immunoassays do not.

What the panel is really buying is a reason to slow down. Macroprolactin, prolactin bound into a large immunologically detectable and biologically inert complex, is present in a meaningful share of people found to have hyperprolactinemia Sharma 2021, and screening policy for it has been studied as a laboratory decision in its own right Smith 2022.

What it cannot settle, and what would

It cannot test for macroprolactin, and that is the first thing that should happen. Macroprolactin is identified by a polyethylene glycol precipitation step performed by the laboratory on the same tube, and it is not automatic on most platforms Smith 2022. You or your clinician have to request it by name. Doing so before anybody images a pituitary prevents a large amount of unnecessary investigation.

It cannot see a pituitary adenoma. That is an MRI, and no prolactin value proves or excludes one Petersenn 2023.

A very large tumor can produce a falsely LOW result, which is the opposite failure and the one nobody expects. At extremely high prolactin concentrations the two-site immunoassay saturates and reports a number far below the truth; the fix is for the laboratory to re-run the sample diluted, and the tumor size thresholds at which this happens have been characterized Yadav 2026. If the clinical picture is dramatic and the prolactin is only mildly raised, ask for the dilution.

And it cannot tell you which of your medications is responsible. Antipsychotics, metoclopramide, domperidone and some antidepressants raise prolactin by design or by side effect, and the only way to know is a supervised change that is a decision for whoever prescribed them Petersenn 2023. Nothing on this page is a reason to stop a psychiatric medication.

Draw conditions that decide whether the money is wasted

This is the most draw-sensitive panel on the site, and every item below has produced a false positive in somebody.

1. Morning, but at least 2 to 3 hours after waking. Prolactin peaks during sleep and falls through the early morning, so a draw taken immediately on waking catches the tail of the nocturnal surge.
2. Sit quietly for 20 to 30 minutes before the needle. Venipuncture stress alone raises prolactin, which is why a single mildly raised value is not treated as a finding Petersenn 2023.
3. No nipple or breast stimulation, no sexual activity and no heavy chest or upper-body training for 24 hours. All three raise it physiologically.
4. No biotin for 72 hours, because it interferes with the immunoassays used for Prolactin, TSH (Thyroid-Stimulating Hormone) and Free T4 (Thyroxine) and it does so in different directions on different platforms Li 2020.
5. Keep taking your prescribed medication and write it on the requisition instead. A drug cause is a likely explanation and identifying it is worth more than a cleaner number.

How you would know it answered your question, and what each pattern means next

Four patterns, and what would have to move for each explanation to be the right one.

• Mildly raised Prolactin, normal LH & FSH and normal sex hormones: repeat under the conditions above and ask for a macroprolactin screen on the same sample. If macroprolactin explains it, the monomeric fraction comes back normal and nothing further is needed Smith 2022Sharma 2021.
• Raised Prolactin with low LH & FSH and a low Total Testosterone or Estradiol, Sensitive (LC/MS-MS): the axis is suppressed. This is the pattern that leads to imaging and to treatment, and successful treatment is confirmed by the gonadotropins and sex hormones recovering rather than by the prolactin alone Petersenn 2023.
• Raised TSH (Thyroid-Stimulating Hormone) with a low Free T4 (Thyroxine): treat the thyroid and re-measure prolactin at 8 to 12 weeks. If the prolactin does not fall with a corrected TSH, the thyroid was not the cause Razvi 2019.
• Raised IGF-1 (Insulin-like Growth Factor 1) alongside a raised Prolactin: a co-secreting adenoma is on the table and this belongs with an endocrinologist rather than a repeat panel Petersenn 2023.

Sources read for these sections

• Smith TP, et al. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia. Clinical Chemistry and Laboratory Medicine 2022 · PMID 35708266
• Sharma LK, et al. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia. Journal of Laboratory Physicians 2021 · PMID 34975255
• Yadav P, et al. The hook effect in macroprolactinomas: tumor size thresholds, prolactin patterns, and clinical consequences - a systematic review. Pituitary 2026 · PMID 42213208
• Petersenn S, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nature Reviews Endocrinology 2023 · PMID 37670148
• Razvi S, et al. Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction. Journal of Thyroid Research 2019 · PMID 31662841
• Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020 · PMID 32445355